AstraZeneca, China and Enhertu
AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...
AstraZeneca Plc’s recent share-price rout has gone so far that the pharma stock has shaken off the last of its bearish ...
We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...
AstraZeneca Pharmaceuticals LP violated federal and Ohio law when it denied a Christian sales specialist an exemption from ...
AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...
Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It ...
The market seemed underwhelmed by last week's earnings announcement from AstraZeneca PLC ( LON:AZN) despite the healthy ...
Dr. Bob Li, a top Asian leader from the New York-based Memorial Sloan Kettering Cancer Center, has become global head of ...
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights ...
Analyst Andrew Berens from Leerink Partners maintained a Buy rating on AstraZeneca (AZN – Research Report) and keeping the price target at ...
Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback